• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Expression and localization of urokinase-type plasminogen activator receptor in human gliomas.

作者信息

Yamamoto M, Sawaya R, Mohanam S, Rao V H, Bruner J M, Nicolson G L, Rao J S

机构信息

Department of Neurosurgery, University of Texas M. D. Anderson Cancer Center, Houston 77030.

出版信息

Cancer Res. 1994 Sep 15;54(18):5016-20.

PMID:8069869
Abstract

Urokinase-type plasminogen activator receptors (uPARs) play an important role in tumor invasion by localizing degradative enzymes at the invasive zone. In the present study, we examined the presence and distribution of uPARs in human gliomas in vivo. The amounts of uPARs were measured by radioreceptor assays and Northern blotting and were significantly higher in anaplastic astrocytomas and glioblastomas than they were in normal brain tissues and low-grade gliomas. In situ hybridization was performed to investigate the cellular source of uPAR mRNA in various types of astrocytomas and normal brain tissues. uPAR mRNA was localized in astrocytoma cells and endothelial cells within tumor tissue, especially near sites of vascular proliferation and at the leading edges of tumors. uPAR mRNA was also expressed in tumor cells near necrotic areas. Expression was barely detectable in low-grade astrocytomas and normal brain tissues. These results suggest that expression of uPAR in the invading astrocytoma cells may play a significant role in the invasive behaviors of glioblastomas.

摘要

相似文献

1
Expression and localization of urokinase-type plasminogen activator receptor in human gliomas.
Cancer Res. 1994 Sep 15;54(18):5016-20.
2
Expression and cellular localization of messenger RNA for plasminogen activator inhibitor type 1 in human astrocytomas in vivo.人星形细胞瘤中1型纤溶酶原激活物抑制剂信使核糖核酸的表达及细胞定位(体内研究)
Cancer Res. 1994 Jul 1;54(13):3329-32.
3
Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo.尿激酶型纤溶酶原激活剂在人星形细胞瘤中的体内表达及定位
Cancer Res. 1994 Jul 15;54(14):3656-61.
4
Expression and significance of urokinase type plasminogen activator gene in human brain gliomas.尿激酶型纤溶酶原激活剂基因在人脑胶质瘤中的表达及意义
J Surg Oncol. 2000 Jun;74(2):90-4. doi: 10.1002/1096-9098(200006)74:2<90::AID-JSO2>3.0.CO;2-7.
5
Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas.人恶性星形细胞瘤中低密度脂蛋白受体相关蛋白/α2-巨球蛋白受体表达增加。
Cancer Res. 1997 Jul 1;57(13):2799-805.
6
Expression and localisation of urokinase-type plasminogen activator gene in gliomas.
J Clin Neurosci. 2000 Mar;7(2):116-9. doi: 10.1054/jocn.1999.0161.
7
Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody.尿激酶型纤溶酶原激活物受体抗体对人胶质母细胞瘤细胞体外侵袭的调节作用
Cancer Res. 1993 Sep 15;53(18):4143-7.
8
Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.组织因子途径抑制物2的表达在人类胶质瘤进展过程中呈负相关。
Clin Cancer Res. 2001 Mar;7(3):570-6.
9
Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.膜型基质金属蛋白酶在人恶性脑肿瘤体内外的差异表达及其与明胶酶A激活的相关性
Cancer Res. 1996 Jan 15;56(2):384-92.
10
In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.反义尿激酶型纤溶酶原激活物受体对人胶质母细胞瘤细胞系侵袭性的体外抑制作用
Oncogene. 1997 Mar 20;14(11):1351-9. doi: 10.1038/sj.onc.1200963.

引用本文的文献

1
The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies.胶质瘤中的 DNA 双链断裂修复:分子参与者和治疗策略。
Mol Neurobiol. 2022 Sep;59(9):5326-5365. doi: 10.1007/s12035-022-02915-2. Epub 2022 Jun 13.
2
Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.尿激酶型纤溶酶原激活物受体(uPAR)作为癌症的治疗靶点。
J Transl Med. 2022 Mar 18;20(1):135. doi: 10.1186/s12967-022-03329-3.
3
The Urokinase Receptor (uPAR) as a "Trojan Horse" in Targeted Cancer Therapy: Challenges and Opportunities.
尿激酶受体(uPAR)作为靶向癌症治疗中的“特洛伊木马”:挑战与机遇
Cancers (Basel). 2021 Oct 27;13(21):5376. doi: 10.3390/cancers13215376.
4
Investigating Glioblastoma Response to Hypoxia.研究胶质母细胞瘤对缺氧的反应。
Biomedicines. 2020 Aug 27;8(9):310. doi: 10.3390/biomedicines8090310.
5
Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment.胶质母细胞瘤分子生物学知识的进展及其对患者诊断、分层和治疗的影响。
Adv Sci (Weinh). 2020 Mar 12;7(9):1902971. doi: 10.1002/advs.201902971. eCollection 2020 May.
6
The unique invasiveness of glioblastoma and possible drug targets on extracellular matrix.胶质母细胞瘤独特的侵袭性及细胞外基质上可能的药物靶点。
Cancer Manag Res. 2019 Feb 25;11:1843-1855. doi: 10.2147/CMAR.S186142. eCollection 2019.
7
The Plasminogen Activation System Promotes Neurorepair in the Ischemic Brain.纤溶酶原激活系统促进缺血性脑的神经修复。
Curr Drug Targets. 2019;20(9):953-959. doi: 10.2174/1389450120666181211144550.
8
Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine.纤溶酶原激活物系统与乳腺癌:在治疗决策和精准医学中的潜在作用
Biomark Insights. 2016 Aug 16;11:105-11. doi: 10.4137/BMI.S33372. eCollection 2016.
9
Recent advances and future of immunotherapy for glioblastoma.胶质母细胞瘤免疫治疗的最新进展和未来。
Expert Opin Biol Ther. 2016 Oct;16(10):1245-64. doi: 10.1080/14712598.2016.1212012. Epub 2016 Jul 27.
10
Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer.转录组学和CRISPR/Cas9技术揭示FOXA2是胰腺癌中的一个肿瘤抑制基因。
Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G1124-37. doi: 10.1152/ajpgi.00035.2016. Epub 2016 May 5.